10X Genomics, Inc. (TXG)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$67.52+3.42%
Close 2026-11-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · TXG
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 62.4% |
| Our one-year growth estimate | diamond | 9.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 53.4 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 66 industry peers
TXG — officer change
Dated 2026-11-02
Director — Ansuman Satpathy, Joseph Gilliam: The filing discloses the appointment of two new directors to the board, which is a standard governance action and not the departure of an executive.
Why it matters: Q2 gross margin reached 74%, helped by lower manufacturing costs and tariff refunds. Results can show whether that gain lasts.
Watch forGross margin stays at or above 74% in a later quarter, without a new one-time gain driving the result.
Also watch forGross margin falls below 70% in a later quarter as manufacturing costs or other costs rise.
Why it matters: Underlying revenue grew 3% in Q2, and management raised its 2026 range. Q3 results test whether that growth continues.
Supportive ifOn November 5, Q3 results show revenue growth that keeps the company on track for $610M–$630M in 2026. This excludes one-time settlement revenue.
Worry ifQ3 results or management's update put 2026 revenue below $610M–$630M. They may also show revenue falling without one-time items.
Why it matters: Spatial consumables revenue grew year over year in both Q1 and Q2. Continued growth would show demand across the existing product line.
Supportive ifQ3 spatial consumables revenue tops $36.4M from the year-earlier quarter.
Worry ifQ3 spatial consumables revenue is $36.4M or less. This reverses Q2's year-over-year growth.
Why it matters: Cash from operations fell from $40.78M in Q4 2025 to $16.97M in Q2 2026. A rise would show progress toward the stated cash-flow goal.
Supportive ifCash from operations tops $16.97M for a quarter and stays above that level in the next reported quarter.
Worry ifQuarterly cash from operations falls below $16.97M or remains at or below that level in two straight reports.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$254 on $10,000 · ±2.5% | How much price usually moves either way. |
| Bad day | $644 loss on $10,000 · 6.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,694 loss on $10,000 · 36.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.